Dual PI3K/mTOR Inhibitor NVP-BEZ235 Leads to a Synergistic Enhancement of Cisplatin and Radiation in Both HPV-Negative and -Positive HNSCC Cell Lines.
- DOI
- 10.3390/cancers14133160
- Published
- 2022 Jun 28
- Container
- Cancers
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/cancers14133160,
title = {Dual PI3K/mTOR Inhibitor NVP-BEZ235 Leads to a Synergistic Enhancement of Cisplatin and Radiation in Both HPV-Negative and -Positive HNSCC Cell Lines.},
author = {Subtil FSB and Gröbner C and Recknagel N and Parplys AC and Kohl S and Arenz A and Eberle F and Dikomey E and Engenhart-Cabillic R and Schötz U},
year = {2022},
journal = {Cancers},
doi = {10.3390/cancers14133160},
url = {https://doi.org/10.3390/cancers14133160}
}RIS
TY - JOUR TI - Dual PI3K/mTOR Inhibitor NVP-BEZ235 Leads to a Synergistic Enhancement of Cisplatin and Radiation in Both HPV-Negative and -Positive HNSCC Cell Lines. AU - Subtil FSB AU - Gröbner C AU - Recknagel N AU - Parplys AC AU - Kohl S AU - Arenz A AU - Eberle F AU - Dikomey E AU - Engenhart-Cabillic R AU - Schötz U PY - 2022 JO - Cancers DO - 10.3390/cancers14133160 UR - https://doi.org/10.3390/cancers14133160 ER -
APA
FSB, S., C, G., N, R., AC, P., S, K., A, A., F, E., E, D., R, E., & U, S. (2022). Dual PI3K/mTOR Inhibitor NVP-BEZ235 Leads to a Synergistic Enhancement of Cisplatin and Radiation in Both HPV-Negative and -Positive HNSCC Cell Lines.. Cancers. https://doi.org/10.3390/cancers14133160
Source records
- pubmed · retrieved 2026-09-25T19:35:40.715Z